ArticleIn vivo (Athens, Greece)

Prognostic Significance of Immune-checkpoint Molecule PD-L1 in Classical Hodgkin Lymphoma: A Clinicopathologic Study of 120 Cases.

Vaclav Kubes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.